Amylyx launches USD 350 million follow-on common stock offering

Reuters2026/08/18 20:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Amylyx launched an underwritten public offering of USD 350 million of common stock.
Underwriters hold a 30-day option to buy up to an additional USD 52.5 million of shares.
Proceeds earmarked for avexitide pre-commercial work, research and development, working capital, general corporate purposes.
Leerink Partners, Morgan Stanley, Guggenheim Securities, LifeSci Capital named joint bookrunners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608181601BIZWIRE_USPR_____20260818_BW657144) on August 18, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Amylyx launches USD 350 million follow-on common stock offering

You may also like

Crypto prices